Brain’s psychosomatic response may induce actual healing

The ability to bring on inflammation psychosomatically helps the body respond to infection “as quickly as possible,” Says Technion professor Asya Rolls.
The research group of Prof. Asya Rolls. Photo by Nitzan Zohar/Technion Spokesperson's Office.
The research group of Prof. Asya Rolls. Photo by Nitzan Zohar/Technion Spokesperson's Office.

Israeli researchers have discovered a link between the brain’s perception of illness and the real thing.

The scientists, from the Technion – Israel Institute of Technology in Haifa, induced inflammation in mice, and after the inflammation subsided, triggered the neurons in the mice’s brains that were active during the initial inflammation.

The result was dramatic: The inflammation re-emerged in the same area as before. Simply “remembering” the inflammation was enough to reactivate it.

The researchers then wondered: If the brain can generate inflammation, can the brain also turn it off?

The answer was a resounding yes. In mice with active inflammation, suppressing the neurons that remembered it produced an immediate reduction in the inflammation.

While there is no guarantee the experiment would work with human beings, it at least raises the possibility of a new therapeutic avenue for treating chronic inflammatory conditions such as Crohn’s disease and psoriasis.

The brain’s ability to bring on illness psychosomatically is more of a feature than a bug, explained professor Asya Rolls, of the Technion’s Faculty of Medicine.

“The body needs to respond to infection as quickly as possible, before the attacking bacteria or viruses can multiply,” she said.

“If certain activity—for example consuming particular foods—has exposed the body to infection and inflammation once, there is an advantage to gearing up for battle when one is about to engage in the same activity again. A shorter response time would allow the body to defeat the infection faster and with less effort.”

The research was led by Tamar Koren, an MD-PhD student in Rolls’ lab. Other participants included Dr. Kobi Rosenblum of the University of Haifa and Dr. Fahed Hakim of EMMS Hospital in Nazareth.

The study was supported by the European Research Council (ERC) Starting Grant, the Allen and Jewel Prince Center for Neurodegenerative Disorders of the Brain, the Howard Hughes Medical Institute (HHMI) and the Wellcome Trust.

Click here to read the full article in Cell.

This article was first published by Israel21c.


Jewish News Syndicate

With geographic, political and social divides growing wider, high-quality reporting and informed analysis are more important than ever to keep people connected.

Our ability to cover the most important issues in Israel and throughout the Jewish world—without the standard media bias—depends on the support of committed readers.

If you appreciate the value of our news service and recognize how JNS stands out among the competition, please click on the link and make a one-time or monthly contribution.

We appreciate your support.